Carotid Stents - A Global Market Perspective

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.GLOBAL MARKET OVERVIEW AND ANALYSIS
Carotid Stents – A Nascent Market!
3.MARKET DYNAMICS
Factors Driving Carotid Stents Market
Clinical Trials & Regulatory Approvals to Accelerate Adoption
Broader Application of CAS
Benefiting From Less-Invasive Nature of Procedure
Acceptance by Various Medical Specialties
Market Challenges
Absence of Sufficient Clinical Data
Surgeons Wary of High-Risk CAS Procedures
Reimbursement Coverage Issue Hurdles Widespread Adoption
Fighting for CAS Domain
Training and Certification of Surgeons – A Major Hurdle
Stenting Procedure for Transient Ischemic Attacks – A Continuing- Dilemma
4.COMPETITIVE SCENARIO
5.PRODUCT FACTS
6.MAJOR CLINICAL TRIALS/STUDIES
Clinical Trials – Key to Higher Adoption of Carotid Stents
Major Clinical Trials & Stent Devices Used
Guidant’s CAPTURE Study
CAPTURE Study Results Hold Promise for Asymptomatic Patients
Boston Scientific’s BEACH Trial
Abbott’s ACT I Trial
CREST Clinical Trial
J&J’s SAPPHIRE Clinical Trial
SAPPHIRE Study Proves Effectiveness of CAS in High-Risk Patients
Other Trials
Medtronic’s MAVErIC Trials Validate the Efficiency of Exponent Carotid Stent
University of Massachusetts Conduct CAS Efficacy Study in Elderly- Patients
CaRESS Study
7.CORPORATE DEVELOPMENTS
Boston Scientific Acquires EndoTex
KNC Obtains Expanded CE Mark Clearance for TriActiv® ProGuard™
FDA Approves Protege® RX Carotid Stent from ev3
8.MAJOR PLAYERS
Abbott Vascular (US)
Boston Scientific Corporation (USA)
ev3, Inc. (USA)
Johnson & Johnson (USA)
Cordis Corporation (USA)
Kensey Nash Corporation (USA)
Medtronic, Inc. (USA)
9.GLOBAL MARKET ANALYTICS
10.THE UNITED STATES
Overview
Factors Affecting Growth
Reimbursement Scenario for CAS
Reimbursements currently offered by the Centers for Medicare and Medicaid Services (CMS)
Restricted Reimbursement Coverage Limits CAS Penetration…
CMS Proposes Expanded Reimbursement Coverage for Carotid Stenting
Absence of Regulatory Approvals – A Major Challenge
Clinical Trials – Key to Higher Adoption of Carotid Stents
Latent Demand
Key Statistics
Major Carotid Stents & EPDs in the Market
US Carotid Stents Market – A Gradual Growth
Trends and Issues
Convenience in Deployment & Use – Critical for Higher Adoption
Rapid Exchange Capabilities Facilitate Effective Control Over Procedures
Carotid Stents Assume the Role of Memory Boosters
Competitive Landscape
11.EUROPE
European Carotid Stents Market – An Overview
ELOCAS Study
CEA Versus CAS
12.REST OF WORLD
Carotid Stenting Scenario in India
Exhibits
Table 1: Market Shares of Leading Players in the Global Carotid Stents Market - 2007E
Table 2: Percentage Breakdown of Number of Carotid Interventions Procedures Worldwide -2008E
Table 3: Global Carotid Stents Market by Region for the Period 2007-2012 (Number of Procedures in Thousands)
Table 4: Percentage Breakdown (in Number) of Global Carotid Stents Market by Region for the Years 2008 & 2009
Table 5: Global Carotid Stents Market by Region for the Period 2007-2012 (Sales in US$ Million)
Table 6: Percentage Breakdown (in Revenue) of Global Carotid Stents Market by Region for the Years 2008 & 2009
Table 7: Percentage Breakdown of Number of Carotid Interventions Procedures in the US –
Table 8: Market Shares of Leading Players in the US Market for Carotid Stents –
Table 9: Carotid Stents Market in the US: 2007-2012 (Number of Procedures in Thousands)
Table 10: Carotid Stents Market in the US: 2007-2012 (Sales in US$ Million)
Table 11: Percentage Breakdown of European Vascular Interventions Market -2006E (Number of Procedures)
Table 12: Carotid Stents Market in Europe: 2007-2012 (Number of Procedures in Thousands)
Table 13: Carotid Stents Market in Europe: 2007-2012 (Sales in US$ Million)
Table 14: Carotid Stents Market in Rest of World: 2007-2012 (Number of Procedures in Thousands)
Table 15: Carotid Stents Market in Rest of World: 2007-2012 (Sales in US$ Million)
Companies Profiled